BPG is committed to discovery and dissemination of knowledge
Citation
Kalashnikova E, Isupova E, Gaidar E, Lubimova N, Sorokina L, Chikova I, Kaneva M, Raupov R, Kalashnikova O, Aliev D, Gaydukova I, Kostik M. Outcomes of a 12-month course of early and late rituximab BCD020 biosimilar administration in juvenile systemic lupus erythematosus: A retrospective study. World J Nephrol 2024; 13(4): 98393 [PMID: 39723361 DOI: 10.5527/wjn.v13.i4.98393]
Please LOGIN to submit a new comment.